Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis. Issue 2 (January 2017) - Hartery, K.; O'Reilly, S.; Houlihan, D.; Doherty, G.; Mulcahy, H.; Cullen, G.; Sheridan, J.